The More Life Company Corp. (CSE:MLCO)

Canada · Delayed Price · Currency is CAD

0.0800

+0.0100 (14.29%)

Aug 28, 2026, 3:42 PM EST

433.33% (1Y)

Market Cap	36.56M +591.7%
Revenue (ttm)	65.00K +32.7%
Net Income	-2.80M
EPS	-0.01
Shares Out	457.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	79,022
Open	0.0650
Previous Close	0.0700
Day's Range	0.0650 - 0.0800
52-Week Range	0.0100 - 0.1050
Beta	-2.72
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About The More Life Company

The More Life Company Corp., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol that enhances solubility for previously insoluble macrocyclic lactone drugs. It also provides licensed Agrarius, an agricultural plant signalling technology. The company was formerly known as Mountain Valley... [Read more]

Industry Biotechnology

Sector Healthcare

CEO Dennis Hancock

Employees 1

Stock Exchange Canadian Securities Exchange

Ticker Symbol MLCO

Full Company Profile

Financial Performance

In fiscal year 2026, The More Life Company's revenue was 65,000, an increase of 32.65% compared to the previous year's 49,000. Losses were -2.80 million, -62.59% less than in 2025.

Financial Statements